跳至主要内容
临床试验/CTRI/2024/08/072845
CTRI/2024/08/072845尚未招募2 期

A phase II randomized controlled trial comparing pectoralis major myocutaneous flap outcomes using conventional and Indocyanine green angiography technique in oral cancers

All India Institute of Medical Sciences1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年9月3日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
30
试验地点
1
主要终点
To determine the outcomes of PMMC flap using ICG compared with conventional technique in terms of flap loss and dehiscence

研究概览

简要总结

After resection of primary in oral cancers, PMMC flap is harvested. PMMC flap is assessed clinically for perfusion by using the colour. Patients randomized to conventional technique will undergo flap inset. Patients randomized to ICGA technique will be given 2.5mg ICG and ICG flouresence system will be used to pick up real-time fluorescent images of the flap to asses perfusion. The flap is then inset into the defect area. Similar procedure repeated after flap inset into the defect. Outcomes assessed in terms of full thickness and partial thickness flap loss at day 5 and day 30.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Biopsy proven cancers of oral cavity Requiring pedicled PMMC flaps for reconstruction.

排除标准

  • Large oral cancers requiring free flaps Secondary primary with prior treatment with chemotherapy or radiotherapy Patients refusing to consent Unresectable disease.

结局指标

主要结局

To determine the outcomes of PMMC flap using ICG compared with conventional technique in terms of flap loss and dehiscence

时间窗: Day 5 and Day 30

次要结局

  • Orocutaneous fistula(Receiving radiotherapy on time)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Hema Siri Kottu

All India Institute of Medical Sciences

研究点 (1)

Loading locations...

相似试验